Is antibiotic prophylaxis still mandatory for transperineal prostate biopsy? Results of a comparative study
- PMID: 35510097
- PMCID: PMC9042783
- DOI: 10.1016/j.prnil.2021.11.001
Is antibiotic prophylaxis still mandatory for transperineal prostate biopsy? Results of a comparative study
Abstract
Introduction and objectives: This study aimed to assess the incidence of urinary tract infections (UTIs) after transperineal prostate biopsy (TP-PB) comparing patients who underwent antibiotic prophylaxis (AP) with patients who had no prophylaxis.
Materials and methods: This prospective, double-center trial was conducted between August and December 2020. Patient candidates to PB were included with 1:1 allocation to case (Group A-no AP) and control group (Group B-standard AP). All TP-PBs were performed in an outpatient setting under local anesthesia. Data collected 2 weeks after the procedure included incidence of UTIs or bacteriuria, evaluated with a urine culture (UC), main symptoms, and complications related to TP-PBs.
Results: A total of 200 patients were included (100 patients in each group). The mean age was 66.2 ± 7.7 in Group A and 67.4 ± 8 years in Group B (P = 0.134). Mean prostate volume was 65.5 ± 26.7 vs. 51 ± 24.6 cc (P < 0.001), number of biopsy cores was 17.8 ± 2.4 vs. 14.9 ± 0.8 (P < 0.001), and PSA value was 15.9 ± 28.1 vs. 13.3 ± 22.3 ng/ml (P = 0.017). Overall PCa detection rate was 55% vs. 59% (P = 0.567). Postoperative UTI occurred in one patient in Group A vs. zero in Group B. Asymptomatic bacteriuria was present in 3 vs. 5 patients (P = 0.470) and was not treated with antibiotics. Postoperative hematuria was observed in 13 patients vs. 29 (P < 0.05), and acute urinary retention was observed in one patient in each group.
Conclusions: The incidence of bacteriuria and UTIs in TP-PBs is not related to AP. Therefore, AP could be discontinued in TP-PB candidates without the risk of increasing UTI-related complications.
Keywords: Antibiotic prophylaxis; Prostate biopsy; Prostate cancer screening; Transperineal.
© 2022 Asian Pacific Prostate Society. Publishing services by Elsevier B.V.
Conflict of interest statement
All Authors certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or nonfinancial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
References
-
- Nam R.K., Saskin R., Lee Y., Liu Y., Law C., Klotz L.H., et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol. 2013 Jan;189(1 Suppl):S12–S17. discussion S17-8. - PubMed
-
- Lindert K.A., Kabalin J.N., Terris M.K. Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol. 2000 Jul;164(1):76–80. - PubMed
-
- Loeb S., Vellekoop A., Ahmed H.U., Catto J., Emberton M., Nam R., et al. Systematic review of complications of prostate biopsy. Eur Urol. 2013 Dec;64(6):876–892. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous